LONDON (Reuters) – Developing countries facing potentially pricey legal challenges from big tobacco firms are to get help from a new $4 million fund created by the philanthropists Bill Gates and Michael Bloomberg.
Announcing the creation of the anti-tobacco trade litigation fund on Wednesday, Bloomberg Philanthropies and the Bill & Melinda Gates Foundation said countries with limited resources should not be bullied into making bad health policy choices.
LONDON, March 18 (Reuters) – Developing countries facing
potentially pricey legal challenges from big tobacco firms are
to get help from a new $4 million fund created by the
philanthropists Bill Gates and Michael Bloomberg.
Announcing the creation of the anti-tobacco trade litigation
fund on Wednesday, Bloomberg Philanthropies and the Bill &
Melinda Gates Foundation said countries with limited resources
should not be bullied into making bad health policy choices.
LONDON, March 17 (Reuters) – As many as 1,000 people a day
in Europe contract tuberculosis, and slow progress against the
disease coupled with rising drug resistance mean the region is
unlikely to defeat it until next century, health officials said
At current rates, the region has little chance of meeting a
target to eliminate it by 2050, according to a joint report by
the World Health Organization (WHO) and the European Centre for
Disease Prevention and Control (ECDC).
LONDON (Reuters) – Pakistani and Bangladeshi people in London’s least healthy boroughs are being asked to provide spit samples and health records to researchers hoping to find genetic clues to why they are disproportionately affected by certain diseases.
The East London Genes and Health project will focus partly on so-called “knock-out” genes — rare in the general population but more frequent in communities where cousins and other close relatives marry and have children, as is more common in Pakistani and Bangladeshi communities.
LONDON (Reuters) – Measles cases could almost double in countries hardest hit by the West African Ebola outbreak as overwhelmed health systems are unable to maintain child immunizations, scientists said on Thursday.
For every extra month that health care systems are disrupted, international researchers said up to 20,000 children aged between nine months and five years were put at risk.
LONDON (Reuters) – Older people at risk of dementia who follow advice on healthy eating, exercise and brain-training can slow down cognitive decline, particularly in their ability to organize and regulate thought processes, researchers said on Thursday.
In the first randomized controlled trial of its kind, the scientists found that two years of intensive guidance for people aged 60 to 77 led to some striking differences in the brain’s capabilities in so-called executive function and processing.
LONDON, March 11 (Reuters) – A wave of H7N9 bird flu in
China that has spread into people may have the potential to
emerge as a pandemic strain in humans, scientists said on
The H7N9 virus, one of several strains of bird flu known to
be able to infect humans, has persisted, diversified and spread
in chickens across China, the researchers said, fuelling a
resurgence of infections in people and posing a wider threat.
LONDON/GENEVA (Reuters) – Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said on Thursday.
Signaling global health authorities’ determination to see through trials despite a sharp drop in cases in the West Africa epidemic, the WHO said a second shot, developed by GlaxoSmithKline will be tested “in a sequential study, as supply becomes available”.
LONDON (Reuters) – British scientists are turning to crowdfunding to complete the first scientific study ever to image the brain of someone “tripping” on the psychedelic drug LSD.
The study, part of a psychedelic research project the scientists say could revolutionize understanding of the human brain, is led by neuroscientists at Imperial College London who now need around 25,000 pounds ($38,000) to finish their work.
LONDON, March 4 (Reuters) – Scientists who analysed
countless chemicals in spider venom say they have identified
seven compounds that block a key step in the body’s ability to
pass pain signals to the brain.
In research they said could one day lead to a new class of
potent painkillers, the scientists focused on 206 species of
spider and searched for molecules in the venom that block nerve
activity, particular via so-called “Nav1.7 channels”.